In conclusion, our study demonstrates that RAB38 is a critical regulator of cell survival in glioblastoma in vitro and strongly indicates RAB38 as a potential therapeutic target singly or in combination therapies for glioblastoma treatment. The gene discussed is RAB38; the disease is glioblastoma.